{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T17:32:41Z","timestamp":1769275961999,"version":"3.49.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,12,22]],"date-time":"2011-12-22T00:00:00Z","timestamp":1324512000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s00535-011-0502-y","type":"journal-article","created":{"date-parts":[[2011,12,21]],"date-time":"2011-12-21T07:17:24Z","timestamp":1324451844000},"page":"366-376","source":"Crossref","is-referenced-by-count":29,"title":["Regulatory T cells expanded by rapamycin in vitro suppress colitis in an experimental mouse model"],"prefix":"10.1007","volume":"47","author":[{"given":"Haruei","family":"Ogino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Iwasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eikich","family":"Ihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotada","family":"Akiho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuaki","family":"Motomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Akahoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisato","family":"Igarashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Kotoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuhide","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoichi","family":"Takayanagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,12,22]]},"reference":[{"key":"502_CR1","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1172\/JCI30587","volume":"117","author":"W Strober","year":"2007","unstructured":"Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest. 2007;117:514\u201321.","journal-title":"J Clin Invest"},{"key":"502_CR2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/1756283X09354136","volume":"3","author":"S Ardizzone","year":"2010","unstructured":"Ardizzone S, Cassinotti A, Manes G, Porro GB. Immunomodulators for all patients with inflammatory bowel disease? Therap Adv Gastroenterol. 2010;3:31\u201342.","journal-title":"Therap Adv Gastroenterol"},{"key":"502_CR3","doi-asserted-by":"crossref","unstructured":"Kahan BD, Camardo JS. Rapamycin: clinical results and future opportunities. Transplantation. 2001;72:1181\u201393.","DOI":"10.1097\/00007890-200110150-00001"},{"key":"502_CR4","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.bbmt.2005.04.006","volume":"11","author":"A Busca","year":"2005","unstructured":"Busca A, Locatelli F, Moscato D, Falda M. Sirolimus-related toxicity in stem cell transplantation. Biol Blood Marrow Transpl. 2005;11:647\u20139.","journal-title":"Biol Blood Marrow Transpl"},{"key":"502_CR5","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev.immunol.14.1.483","volume":"14","author":"RT Abraham","year":"1996","unstructured":"Abraham RT, Wiederrecht GJ. Immunopharmacology of rapamycin. Annu Rev Immunol. 1996;14:483\u2013510.","journal-title":"Annu Rev Immunol"},{"key":"502_CR6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.trim.2007.01.002","volume":"17","author":"Y Qu","year":"2007","unstructured":"Qu Y, Zhang B, Zhao L, Liu G, Ma H, Rao E, et al. The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+ T cells in mice. Transpl Immunol. 2007;17:153\u201361.","journal-title":"Transpl Immunol"},{"key":"502_CR7","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00384-005-0793-7","volume":"21","author":"S Farkas","year":"2006","unstructured":"Farkas S, Hornung M, Sattler C, Guba M, Steinbauer M, Anthuber M, et al. Rapamycin decreases leukocyte migration in vivo and effectively reduces experimentally induced chronic colitis. Int J Colorectal Dis. 2006;21:747\u201353.","journal-title":"Int J Colorectal Dis"},{"key":"502_CR8","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2249.2007.03345.x","volume":"148","author":"C Matsuda","year":"2007","unstructured":"Matsuda C, Ito T, Song J, Mizushima T, Tamagawa H, Kai Y, et al. Therapeutic effect of a new immunosuppressive agent, everolimus, on interleukin-10 gene-deficient mice with colitis. Clin Exp Immunol. 2007;148:348\u201359.","journal-title":"Clin Exp Immunol"},{"key":"502_CR9","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.intimp.2007.08.027","volume":"7","author":"H Kopf","year":"2007","unstructured":"Kopf H, de la Rosa GM, Howard OM, Chen X. Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+ T regulatory cells. Int Immunopharmacol. 2007;7:1819\u201324.","journal-title":"Int Immunopharmacol"},{"key":"502_CR10","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s10620-010-1286-2","volume":"56","author":"H Ogino","year":"2011","unstructured":"Ogino H, Nakamura K, Ihara E, Akiho H, Takayanagi R. CD4(+)CD25(+) regulatory T cells suppress Th17-responses in an experimental colitis model. Dig Dis Sci. 2011;56:376\u201386.","journal-title":"Dig Dis Sci"},{"key":"502_CR11","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1080\/14653240802345812","volume":"10","author":"Y Sumida","year":"2008","unstructured":"Sumida Y, Nakamura K, Kanayama K, Akiho H, Teshima T, Takayanagi R. Preparation of functionally preserved CD4+CD25high regulatory T cells from leukapheresis products from ulcerative colitis patients, applicable to regulatory T-cell transfer therapy. Cytotherapy. 2008;10:698\u2013710.","journal-title":"Cytotherapy"},{"key":"502_CR12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0022-1759(94)90236-4","volume":"171","author":"AB Lyones","year":"1994","unstructured":"Lyones AB, Parish CR. Determination of lymphocyte division by flow cytometry. J Immunol Methods. 1994;171:131\u20137.","journal-title":"J Immunol Methods"},{"key":"502_CR13","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000068150","volume":"70","author":"J Mudter","year":"2002","unstructured":"Mudter J, Wirtz S, Galle PR, Neurath MF. A new model of chronic colitis in SCID mice induced by adoptive transfer of CD62L+CD4+ T cells: insights into the regulatory role of interleukin-6 on apoptosis. Pathobiology. 2002;70:170\u20136.","journal-title":"Pathobiology"},{"key":"502_CR14","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1136\/gut.2005.072801","volume":"55","author":"MC Fantini","year":"2006","unstructured":"Fantini MC, Becker C, Tubbe I, Nikolaev A, Lehr HA, Galle P, et al. Transforming growth factor \u03b2 induced FoxP3+ regulatory T cells suppress Th1 mediated experimental colitis. Gut. 2006;55:671\u201380.","journal-title":"Gut"},{"key":"502_CR15","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1097\/01.MIB.0000191611.05466.1f","volume":"11","author":"K Honda","year":"2005","unstructured":"Honda K, Nakamura K, Matsui N, Takahashi M, Kitamura Y, Mizutani T, et al. T helper 1-inducing property of IL-27\/WSX-1 signaling is required for the induction of experimental colitis. Inflamm Bowel Dis. 2005;11:1044\u201352.","journal-title":"Inflamm Bowel Dis"},{"key":"502_CR17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1677\/ERC-10-0126","volume":"18","author":"A Kasajima","year":"2011","unstructured":"Kasajima A, Pavel M, Darb-Esfahani S, Noske A, Stenzinger A, Sasano H, et al. mTOR expression and activity patterns in gastroenteropancreatic neuroendocrine tumours. Endocr Relat Cancer. 2011;18:181\u201392.","journal-title":"Endocr Relat Cancer"},{"key":"502_CR18","doi-asserted-by":"crossref","first-page":"8338","DOI":"10.4049\/jimmunol.177.12.8338","volume":"177","author":"M Battaglia","year":"2006","unstructured":"Battaglia M, Stabilini A, Migliavacca B, Horejs-Hoeck J, Kaupper T, Roncarolo MG. Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients. J Immunol. 2006;177:8338\u201347.","journal-title":"J Immunol"},{"key":"502_CR19","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0092-8674(00)80856-9","volume":"101","author":"S Sakaguchi","year":"2000","unstructured":"Sakaguchi S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell. 2000;101:455\u20138.","journal-title":"Cell"},{"key":"502_CR20","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1093\/intimm\/10.12.1969","volume":"10","author":"T Takahashi","year":"1998","unstructured":"Takahashi T, Kuniyasu Y, Toda M, Sakaguchi N, Itoh M, Iwata M, et al. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic\/suppressive state. Int Immunol. 1998;10:1969\u201380.","journal-title":"Int Immunol"},{"key":"502_CR21","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.4049\/jimmunol.170.8.3939","volume":"170","author":"C Mottet","year":"2003","unstructured":"Mottet C, Uhlig HH, Powrie F. Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J Immunol. 2003;170:3939\u201343.","journal-title":"J Immunol"},{"key":"502_CR22","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1053\/j.gastro.2005.03.043","volume":"128","author":"J Maul","year":"2005","unstructured":"Maul J, Loddenkemper C, Mundt P, Berg E, Giese T, Stallmach A, et al. Peripheral and intestinal regulatory CD4+CD25(high) T cells in inflammatory bowel disease. Gastroenterology. 2005;128:1868\u201378.","journal-title":"Gastroenterology"},{"key":"502_CR23","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s10620-006-3191-2","volume":"51","author":"M Takahashi","year":"2006","unstructured":"Takahashi M, Nakamura K, Honda K, Kitamura Y, Mizutani T, Araki Y, et al. An inverse correlation of human peripheral blood regulatory T cell frequency with the disease activity of ulcerative colitis. Dig Dis Sci. 2006;51:677\u201386.","journal-title":"Dig Dis Sci"},{"key":"502_CR24","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.4049\/jimmunol.173.5.3119","volume":"173","author":"S Makita","year":"2004","unstructured":"Makita S, Kanai T, Oshima S, Uraushihara K, Totsuka T, Sawada T, et al. CD4+CD25bright T cells in human intestinal lamina propria as regulatory cells. J Immunol. 2004;173:3119\u201330.","journal-title":"J Immunol"},{"key":"502_CR25","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/00054725-200606000-00003","volume":"12","author":"N Holm\u00e9n","year":"2006","unstructured":"Holm\u00e9n N, Lundgren A, Lundin S, Bergin AM, Rudin A, Sj\u00f6vall H, et al. Functional CD4+CD25 high regulatory T cells are enriched in the colonic mucosa of patients with active ulcerative colitis and increase with disease activity. Inflamm Bowel Dis. 2006;12:447\u201356.","journal-title":"Inflamm Bowel Dis"},{"key":"502_CR26","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1182\/blood-2004-10-3932","volume":"105","author":"M Battaglia","year":"2005","unstructured":"Battaglia M, Stabilini A, Roncarolo MG. Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood. 2005;105:4743\u20138.","journal-title":"Blood"},{"key":"502_CR27","doi-asserted-by":"crossref","first-page":"320","DOI":"10.4049\/jimmunol.178.1.320","volume":"178","author":"L Strauss","year":"2007","unstructured":"Strauss L, Whiteside TL, Knights A. Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin. J Immunol. 2007;178:320\u20139.","journal-title":"J Immunol"},{"key":"502_CR28","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1111\/j.1600-6143.2007.01842.x","volume":"7","author":"W Gao","year":"2007","unstructured":"Gao W, Lu Y, El Essawy B. Contrasting effects of cyclosporine and rapamycin in de novo generation of alloantigen-specific regulatory T cells. Am J Transpl. 2007;7:1722\u201332.","journal-title":"Am J Transpl"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-011-0502-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-011-0502-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-011-0502-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T04:21:38Z","timestamp":1561090898000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-011-0502-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,22]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["502"],"URL":"https:\/\/doi.org\/10.1007\/s00535-011-0502-y","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,22]]}}}